Imaging Method Has Potential to Predict Effectiveness of Induction Chemotherapy in Patients With Head and Neck CancerOctober 01, 2015
Researchers identified a potential new way to predict which patients with head and neck cancer will benefit most from chemotherapy.
Low-risk cancers that are asymptomatic and presumably will not cause problems in the future are responsible for the rapid increase in the number of new thyroid cancer diagnoses over the past decade, according to a study.
Researchers have discovered that determining a tumor's medulloblastoma subgroup can be achieved noninvasively, using magnetic resonance spectroscopy (MRS).
Researchers have developed a magnetic resonance imaging (MRI) contrast agent with the capability to pinpoint much smaller aggressive breast cancer tumors and micrometastases.
New molecular tools are emerging to identify lung adenocarcinomas during pulmonary resection. The results of a proof-of-concept study suggest that fluorescent imaging of lung cancer during surgery using targeted molecular agents may soon be a reality.
Classification system offers precise determination of effectiveness of surgical resection of gliomasAugust 11, 2015
A new procedure for analyzing radiologic imaging scans increases the chance to accurately predict the course of malignant gliomas.
With the availability of tomosynthesis mammography, should women at high risk for developing breast cancer still undergo annual MRI?
BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.
A new, accurate imaging technique, combining photoacoustics with nanosensors, has been developed for the noninvasive screening of lymph nodes for metastatic cancer.
Preoperative navigated transcranial magnetic stimulation (nTMS) analysis of motor areas can improve the prognosis for patients with malignant brain tumors.
PET-CT guided active surveillance for patients with locally advanced head and neck squamous cell cancer is an option over node dissection, per analysis data presented at the 2015 American Society of Clinical Oncology annual meeting.
Magnetic resonance imaging (MRI) can provide vital information for predicting the odds of breast cancer development.
Tomosynthesis detects 40% more breast cancers than traditional mammography does, according to a major screening study.
Digital breast tomosynthesis increases the rate of cancer detection in women with dense breast tissue by as much as 67%, according to research.
Although FDG PET/CT is appropriate for systemic staging of newly diagnosed stage III breast cancer, the technique may not be equally valuable for all breast cancer histologies, research indicates.
A magnetic resonance imaging (MRI)-based screening program for persons at high risk of pancreatic cancer identified pancreatic lesions in 40% of patients, according to an online report.
For men with nonmetastatic castration resistant prostate cancer with a negative bone scan after diagnosis, factors associated with a second bone scan include higher PSA, shorter PSA doubling time, and faster PSA velocity; but under- and over-imaging may also be a factor.
Study data suggests that magnetic resonance imaging (MRI) could one day make biopsies more effective, or even replace them altogether, via noninvasive detection of telltale sugar molecules shed by the outer membranes of cancerous cells.
Present barriers for the usual dosimetry accompanying photodynamic therapy (PDT) for late-stage pancreatic cancer can be overcome via clinical technologies.
When low-dose computed tomography is used for second and subsequent lung cancer screening, the rate of repeating early repeat scans for suspicious findings decreased by more than 80%.
Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)April 01, 2015
The International Lymphoma Radiation Oncology Group (ILROG) has issued a guideline outlining use of 3-D computed tomography (CT)-based radiation therapy planning.
An association of high rates of inappropriate imaging for prostate cancer and breast cancer found in a study of Medicare beneficiaries suggests that regional culture could contribute to inappropriate imaging.
Detection of asymptomatic thyroid nodules has increased, and the majority of benign thyroid nodules examined did not lead to a diagnosis of thyroid cancer, according to a recent study.
Magnetic resonance spectroscopy (MRS) shows precancerous breast changes in women with BRCA gene mutationMarch 16, 2015
MRS that incorporates monitoring of biochemical changes in tissue could improve the management of women at risk of breast cancer, according to a new study.
Research indicates a high value of scans that could lead to future change of reimbursement policies for follow-up PET/CT studies in lung cancer.
Not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all underarm nodes removed, new research indicates.
Targeted magnetic resonance (MR)/ultrasound fusion biopsy outperformed standard biopsy technique for increased detection of high-risk prostate cancer, according to a recent study.
Lower use of imaging seen in the VA than in fee-for-service Medicare; not associated with less geographic variation.
A novel medical-imaging technology, TexRAD, which analyzes the texture of tumors, has been shown in trials to enable early diagnosis of colorectal cancer in patients not responding to the standard cancer therapy better than other available tumor markers.
Diffuse optical spectroscopic tomographic imaging (DOST) may be useful in predicting which patients will best respond to chemotherapy used to reduce breast cancer tumors before surgery, according to a new study.
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Late-Stage Lung Cancer Often Overtreated
- Patients With Multiple Myeloma Vulnerable to Financial Toxicity Due to Costly Treatments
- Biomarker May Predict Prognosis for Targeted Therapy in Patients With HER2-Negative Breast Cancer
- New Approach Tackles Hormone Therapy Resistance in Breast Cancer
- Risk of cardiovascular events higher after antiangiogenic therapy for RCC in persons older than 65 years
- Chemotherapy Use Associated with Survival Benefit Among Medicare Patients with SCLC
- Patient-Reported Physical Functioning May Predict HCT Outcomes
- CT Scans for Lung Cancer Result in Low Number of False-Positives
- Artificial Intelligence May Better Predict Response in Breast Cancer Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|